Brevibloc Direct
Brevibloc (generic name ) is a cardioselective beta-1 receptor blocker used for the rapid, short-term control of heart rate and blood pressure in acute settings. Its defining characteristic is its ultra-short duration of action, with an elimination half-life of approximately 9 minutes . Core Medical Uses
When a rapid heart rate requires specific medical intervention. Esmolol: Uses, Interactions, Mechanism of Action | DrugBank brevibloc
Rapidly controlling ventricular rate in conditions like atrial fibrillation or atrial flutter. Brevibloc (generic name ) is a cardioselective beta-1
Brevibloc is primarily indicated for patients requiring immediate but temporary beta-blockade, such as: or emergence from anesthesia.
Treating high heart rate and blood pressure that occur during surgery, induction, or emergence from anesthesia.